Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model.

@article{Ceyhan2011ComparisonOA,
  title={Comparison of aromatase inhibitor (letrozole) and immunomodulators (infliximab and etanercept) on the regression of endometriotic implants in a rat model.},
  author={Seyit Temel Ceyhan and Onder Onguru and Ulaş Fidan and Tayfun Ide and H. Ruhi Yaman and Selim Kiliç and Iskender Başer},
  journal={European journal of obstetrics, gynecology, and reproductive biology},
  year={2011},
  volume={154 1},
  pages={100-4}
}
OBJECTIVE Novel treatment strategies are needed in the treatment of endometriosis due to limited success rates with the currently available options. As inflammatory and immunological mechanisms have been shown to be involved in the mechanism of the disease, new modalities are likely to emerge. We investigated the effects of infliximab (INF), etanercept (ETA) and letrozole on the regression of experimental endometriosis. STUDY DESIGN In this experimental randomized trial, endometriosis was… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Effect of the immunomodulator leflunomideontheinductionofendometriosis in anexperimentalrat model

  • H Aytan, P Caglar, D Uygur, S Zergeroğlu, S. Batıoglun
  • Fertil Steril
  • 2007
1 Excerpt

Changes in the T-helper cytokine profile and in lymphocyte activation at the systemic and local levels in women with endometriosis

  • YS Antsiferova, NY Satnikova, LV Posiseeva, AC. Shor
  • Fertil Steril 2005;84:1705–11
  • 2005
1 Excerpt

Similar Papers

Loading similar papers…